VolitionRx Limited (VNRX)
VolitionRx Statistics
Share Statistics
VolitionRx has 103.02M shares outstanding. The number of shares has increased by 15.72% in one year.
| 103.02M |
| 15.72% |
| 0% |
| 21.27% |
| 76.14M |
| 11,132 |
| 3.69% |
Short Selling Information
The latest short interest is 185.86K, so 0.18% of the outstanding shares have been sold short.
| 185.86K |
| 0.18% |
| 0.25% |
| 1 |
Valuation Ratios
The PE ratio is -1.93 and the forward PE ratio is -12.89. VolitionRx's PEG ratio is 0.05.
| -1.93 |
| -12.89 |
| 42.09 |
| 0.4 |
| -2.08 |
| -1.98 |
| 0.05 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for VolitionRx.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 0.52, with a Debt / Equity ratio of -0.23.
| 0.52 |
| 0.52 |
| -0.23 |
| -0.23 |
| -0.22 |
| -79.4 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $14,511.89 |
| $-317,268.66 |
| 85 |
| 0.13 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by 24.59% in the last 52 weeks. The beta is 1.06, so VolitionRx's price volatility has been higher than the market average.
| 1.06 |
| 24.59% |
| 0.54 |
| 0.61 |
| 61.71 |
| 301,319 |
Income Statement
In the last 12 months, VolitionRx had revenue of 1.23M and earned -26.97M in profits. Earnings per share was -0.31.
| 1.23M |
| 1.23M |
| -27.02M |
| -26.97M |
| -25.62M |
| -26.92M |
| -0.31 |
Balance Sheet
The company has 3.26M in cash and 5.82M in debt, giving a net cash position of -2.56M.
| 3.26M |
| 5.82M |
| -2.56M |
| -229.54M |
| 8.52M |
| -4.98M |
Cash Flow
In the last 12 months, operating cash flow was -25.89M and capital expenditures -574K, giving a free cash flow of -26.47M.
| -25.89M |
| -574K |
| -26.47M |
| -0.3 |
Margins
Gross margin is -5.57%, with operating and profit margins of -2190.9% and -2186.27%.
| -5.57% |
| -2190.9% |
| -2209.79% |
| -2186.27% |
| -2076.62% |
| -2190.9% |
| -2145.66% |
Dividends & Yields
VNRX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for VNRX is $4, which is 426.3% higher than the current price. The consensus rating is "Buy".
| $4 |
| 426.3% |
| Buy |
| 5 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -45.31 |
| 4 |